KOD (STOCKS)
Kodiak Sciences Inc Common Stock
$36.140000
+0.430000 (+1.20%)
Prev close: $35.710000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Victor Perlroth
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,255.33M
- Employees
- 121
- P/E (TTM)
- -8.66
- P/B (TTM)
- 20.04
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
8
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.94 | $-1.02 | +0.0826 | +8.08% |
|
Dec 2025 (Q4)
|
$-1.04 | $-1.06 | +0.0239 | +2.25% |
|
Sep 2025 (Q3)
|
$-1.16 | $-1.04 | -0.1207 | -11.61% |
|
Jun 2025 (Q2)
|
$-1.03 | $-1.08 | +0.0477 | +4.43% |
Financial Statements
| Revenues | $0.00 |
| Operating Expenses | $235.09M |
| Research and Development | $187.28M |
| Other Operating Expenses | $47.82M |
| Operating Income/Loss | -$235.09M |
| Income/Loss From Continuing Operations After Tax | -$230.66M |
| Income/Loss From Continuing Operations Before Tax | -$230.61M |
| Net Income/Loss | -$230.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$230.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$230.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.17 |
| Diluted Earnings Per Share | -$4.17 |
| Basic Average Shares | 62,321,478 |
| Diluted Average Shares | 62,321,478 |
| Assets | $306.01M |
| Current Assets | $175.26M |
| Noncurrent Assets | $130.75M |
| Fixed Assets | $81.51M |
| Other Non-current Assets | $49.24M |
| Liabilities | $193.91M |
| Current Liabilities | $49.57M |
| Accounts Payable | $11.34M |
| Wages | $8.48M |
| Other Current Liabilities | $29.75M |
| Noncurrent Liabilities | $144.33M |
| Equity | $112.10M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $112.10M |
| Liabilities And Equity | $306.01M |
| Net Cash Flow From Operating Activities | -$146.94M |
| Net Cash Flow From Operating Activities, Continuing | -$146.94M |
| Net Cash Flow From Investing Activities | -$1.18M |
| Net Cash Flow From Investing Activities, Continuing | -$1.18M |
| Net Cash Flow From Financing Activities | $178.80M |
| Net Cash Flow From Financing Activities, Continuing | $178.80M |
| Net Cash Flow | $30.68M |
| Net Cash Flow, Continuing | $30.68M |
| Comprehensive Income/Loss | -$230.66M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$230.66M |
| Other Comprehensive Income/Loss | -$229.97M |